カテゴリー： Market Monitor Global, 世界, 医療/バイオ

咳喘息（CVA）治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Cough Variant Asthma (CVA) Treatment Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2176）◆商品コード：MMG23FB2176
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の咳喘息（CVA）治療薬市場規模と予測を収録しています。・世界の咳喘息（CVA）治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の咳喘息（CVA）治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の咳喘息（CVA）治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「気管支拡張剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

咳喘息（CVA）治療薬のグローバル主要企業は、GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、咳喘息（CVA）治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の咳喘息（CVA）治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：タイプ別市場シェア、2022年
・気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体

世界の咳喘息（CVA）治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の咳喘息（CVA）治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の咳喘息（CVA）治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における咳喘息（CVA）治療薬のグローバル売上、2018年-2023年
・主要企業における咳喘息（CVA）治療薬のグローバル売上シェア、2022年
・主要企業における咳喘息（CVA）治療薬のグローバル販売量、2018年-2023年
・主要企業における咳喘息（CVA）治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
咳喘息（CVA）治療薬市場の定義
市場セグメント
世界の咳喘息（CVA）治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の咳喘息（CVA）治療薬市場規模
世界の咳喘息（CVA）治療薬市場規模：2022年 VS 2029年
世界の咳喘息（CVA）治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの咳喘息（CVA）治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の咳喘息（CVA）治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：気管支拡張剤、ロイコトリエン拮抗剤、肥満細胞安定剤、コルチコステロイド、モノクローナル抗体
咳喘息（CVA）治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
咳喘息（CVA）治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別咳喘息（CVA）治療薬市場規模 2022年と2029年
地域別咳喘息（CVA）治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、Merck & Co、AstraZeneca、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis International、Boehringer Ingelheim、Sunovion Pharmaceuticals
...

This report aims to provide a comprehensive presentation of the global market for Cough Variant Asthma (CVA) Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cough Variant Asthma (CVA) Treatment Drug. This report contains market size and forecasts of Cough Variant Asthma (CVA) Treatment Drug in global, including the following market information:
Global Cough Variant Asthma (CVA) Treatment Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cough Variant Asthma (CVA) Treatment Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Bronchodilators Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cough Variant Asthma (CVA) Treatment Drug include GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim and Sunovion Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cough Variant Asthma (CVA) Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Cough Variant Asthma (CVA) Treatment Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cough Variant Asthma (CVA) Treatment Drug Market Segment Percentages, by Type, 2022 (%)
Bronchodilators
Leukotriene Antagonists
Mast Cell Stabilizers
Corticosteroids
Monoclonal Antibody
Global Cough Variant Asthma (CVA) Treatment Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cough Variant Asthma (CVA) Treatment Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Cough Variant Asthma (CVA) Treatment Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cough Variant Asthma (CVA) Treatment Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cough Variant Asthma (CVA) Treatment Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cough Variant Asthma (CVA) Treatment Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck & Co
AstraZeneca
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cough Variant Asthma (CVA) Treatment Drug, market overview.
Chapter 2: Global Cough Variant Asthma (CVA) Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Cough Variant Asthma (CVA) Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cough Variant Asthma (CVA) Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cough Variant Asthma (CVA) Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cough Variant Asthma (CVA) Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cough Variant Asthma (CVA) Treatment Drug Overall Market Size
2.1 Global Cough Variant Asthma (CVA) Treatment Drug Market Size: 2022 VS 2029
2.2 Global Cough Variant Asthma (CVA) Treatment Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cough Variant Asthma (CVA) Treatment Drug Players in Global Market
3.2 Top Global Cough Variant Asthma (CVA) Treatment Drug Companies Ranked by Revenue
3.3 Global Cough Variant Asthma (CVA) Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Cough Variant Asthma (CVA) Treatment Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cough Variant Asthma (CVA) Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cough Variant Asthma (CVA) Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Cough Variant Asthma (CVA) Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Cough Variant Asthma (CVA) Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Market Size Markets, 2022 & 2029
4.1.2 Bronchodilators
4.1.3 Leukotriene Antagonists
4.1.4 Mast Cell Stabilizers
4.1.5 Corticosteroids
4.1.6 Monoclonal Antibody
4.2 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
4.2.1 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
4.2.2 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
4.2.3 By Type – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
5.2.1 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
5.2.2 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
5.2.3 By Application – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Market Size, 2022 & 2029
6.2 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue & Forecasts
6.2.1 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2023
6.2.2 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue, 2024-2029
6.2.3 By Region – Global Cough Variant Asthma (CVA) Treatment Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.3.2 US Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.3.3 Canada Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.3.4 Mexico Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.4.2 Germany Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.3 France Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.4 U.K. Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.5 Italy Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.6 Russia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.7 Nordic Countries Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.4.8 Benelux Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.5.2 China Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.3 Japan Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.4 South Korea Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.5 Southeast Asia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.5.6 India Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.6.2 Brazil Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.6.3 Argentina Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cough Variant Asthma (CVA) Treatment Drug Revenue, 2018-2029
6.7.2 Turkey Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.3 Israel Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
6.7.5 UAE Cough Variant Asthma (CVA) Treatment Drug Market Size, 2018-2029
7 Cough Variant Asthma (CVA) Treatment Drug Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.1.4 GlaxoSmithKline Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.2.4 Merck & Co Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.3.4 AstraZeneca Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Company Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.4.4 F. Hoffmann-La Roche Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.4.5 F. Hoffmann-La Roche Key News & Latest Developments
7.5 Teva Pharmaceutical
7.5.1 Teva Pharmaceutical Company Summary
7.5.2 Teva Pharmaceutical Business Overview
7.5.3 Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.5.4 Teva Pharmaceutical Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceutical Key News & Latest Developments
7.6 Novartis International
7.6.1 Novartis International Company Summary
7.6.2 Novartis International Business Overview
7.6.3 Novartis International Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.6.4 Novartis International Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.6.5 Novartis International Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.7.4 Boehringer Ingelheim Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Sunovion Pharmaceuticals
7.8.1 Sunovion Pharmaceuticals Company Summary
7.8.2 Sunovion Pharmaceuticals Business Overview
7.8.3 Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Major Product Offerings
7.8.4 Sunovion Pharmaceuticals Cough Variant Asthma (CVA) Treatment Drug Revenue in Global Market (2018-2023)
7.8.5 Sunovion Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 咳喘息（CVA）治療薬の世界市場見通し2023年-2029年(Cough Variant Asthma (CVA) Treatment Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 慢性閉塞性肺疾患治療薬の世界市場見通し2023年-2029年
  • 好酸球性喘息治療薬の世界市場見通し2023年-2029年
  • 先天性高インスリン症（HI）治療薬の世界市場見通し2023年-2029年
  • 尿路感染症（UTI）治療薬の世界市場見通し2023年-2029年
  • 世界の好酸球性喘息治療薬市場インサイト及び予測（静脈内注入、皮下注射）